Alyeska Investment Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-244,574	Closed	-$893K	–	525
2017 Q2	$893K	Sell	244,574 -7,414	-3%	-$27.1K	0.01%	398
2017 Q1	$1.31M	Buy	+251,988	New	+$1.31M	0.01%	411
2014 Q1	–	Sell	-50,000	Closed	-$832K	–	352
2013 Q4	$832K	Buy	+50,000	New	+$832K	0.03%	233